anti-CD9 mAb (Osaka University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameanti-CD9 mAb (Osaka University)

Drug Alias NameALB-6

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionCD9 antigen inhibitors

TargetsCD9 antigen

Therapy Area/IndicationsStomach Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesOsaka University

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesOsaka University

Active IndicationsN/A

Inactive IndicationsStomach Neoplasms

ATC CodeN/A